source
- Iambic Therapeutics targets $135M IPO to fund clinical trials of HER2 and KIF18A cancer drugsIambic Therapeutics, a San Diego AI‑driven biotech, filed to raise $135 million in net proceeds through an initial public offering. The company plans to sell 9.4 million shares at $15 to $17 each,…
- Tailored breast cancer care for older women gains momentum as researchers highlight age-specific tumor differencesOlder women represent a large share of breast cancer diagnoses, with nearly half of cases occurring in patients 65 or older and about one-fifth in those 75 and older. Despite these numbers, clinic…